“Hong Kong is a busy, crowded city with many tall buildings, traffic jams and limited access to Hyperbaric Chambers, making the treatment of Carbon Monoxide (CO) Poisoning a real challenge. The ClearMate™, based on the science of Isocapnic Hyperpnea, is used for treating Carbon Monoxide Poisoning right at point of care, making it a perfect fit for the needs of Hong Kong and Macau,” says Jules Flach, Founder and CEO of Pacific Medical Systems Limited.  “The ClearMate™ is also fully aligned with our business focus in Point of Care, Surgery and Pre-Hospital Emergencies. We look forward to working closely with Thornhill Medical and are excited about the opportunities the ClearMate™ offers.”

Robert J. Sullivan, Vice-President Sales, Thornhill Medical, adds: “Thornhill Medical’s innovative medical technologies are changing the global face of emergency medicine. The ClearMate™ equips first responders with an easy to use, highly portable, point-of-care solution for treating Carbon Monoxide Poisoning and enhancing the elimination of other volatile hydrocarbons, such as ethanol and anaesthetic agents from the blood. With the increasing global awareness and demand for the ClearMate™, we are very happy to extend our distribution coverage with Pacific Medical Systems Limited for Hong Kong and Macau”.

More info: Thornhill Medical